Why BioNTech Stock Is Jumping Today
Shares of BioNTech (NASDAQ: BNTX) were jumping 6.7% higher as of 11:03 a.m. EST on Monday. The gain came after a spokesperson for the European Commission confirmed that the commission is in discussions with BioNTech and its partner Pfizer (NYSE: PFE) about potentially ordering more doses of COVID-19 vaccine BNT162b2, marketed as Comirnaty.
The European Commission initially placed an order for 200 million doses of BNT162b2 in November 2020. In December, it exercised an option to obtain another 100 million doses of the vaccine.
Image source: Getty Images.
Source Fool.com